Cerca un progetto di ricerca

Cerca un progetto di ricerca

Altra/e opzione/i di ricerca

173 Risultato/i

Progetti di ricerca

GliMR2.0: Glioma MR Imaging 2.0 - AT Institution: Information not provided - AT

GliomaSignals: Metabolic control of tumour growth and epileptogenesis: the case of gliomas European Commission DG Research - Directorate General for Research

GliomaSignals: Metabolic control of tumour growth and epileptogenesis: the case of gliomas Inserm-ANRS Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)

Functional role of genes and pathways in histone H3 mutated gliomas Institut für Neuropathologie der Medizinischen Fakultät Münster Institut für Neuropathologie

GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients Universitätsmedizin Mainz Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature? Beaumont Hospital Medical Oncology Service

Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature? Cancer Trials Ireland

Potential predictive biomarkers of anti-RTKs therapy response in gliomas: An in vitro and in vivo Study. Universidade do Minho Grupo de Neurociências

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa Unidade de Investigação e Desenvolvimento

Novel strategies to target treatment resistance in gliomas, focusing on tumor micro-environment and its regulators Instituto de Investigación Hospital 12 de Octubre Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre

Molecular and Cellular Mechanisms of Choroid Plexus Tumor Sanford Research Zhao Lab

Targeting histone demethylase activity for the treatment of pediatric brainstem glioma Institution: Information not provided - US

Targeting Prostaglandin Receptor EP2 for Glioma and Associated Epilepsy Institution: Information not provided - US

CeNo2 - Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem - SE Karolinska Universitetssjukhuset Karolinska University Hospital

Molecular mechanisms of the origine of glioma development Uppsala Universitet Department of immunology, Genetics and Pathology, IGP

Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla Universitätsspital Inselspital Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

To reveal and target molecular interactions causative for pro-invasive signaling in malignant brain tumors Universitäts-Kinderspital Zürich Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

Rational Small Molecule Inhibition of Dissemination (RaSMID) for pediatric brain tumors Universitäts-Kinderspital Zürich Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT Allgemeines Krankenhaus der Stadt Wien Universitätsklinik für Kinder- und Jugendheilkunde

PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT Gesundheit Österreich GmbH

ITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT Medizinische Universität Wien Institut für Krebsforschung

Christian Doppler Laboratory for Next Generation CAR-T Cells St. Anna Kinderkrebsforschung Children's Cancer Research Institute

Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT St. Anna Kinderkrebsforschung

Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation Universitair Ziekenhuis Brussel Universitair Ziekenhuis Brussel (UZ Brussel)

Glioma2015: Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients and Setting up a Large-scale, Prospective Database for Glioma Patients Treated in UZ Leuven UZ Leuven - Campus Gasthuisberg Dienst Neurochirurgie

Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers Hospital for Sick Children, Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer Hospital for Sick Children, Research Institute

Identification and characterization of genes involved in the genesis and progression of pediatric astrocytomas Montreal Children's Hospital Research Institute - McGill University Department of Pediatrics / Département de pédiatrie

Role of chromatin remodeling in the genesis of pediatric and young adult astrocytomes Montreal Children's Hospital Research Institute - McGill University Department of Pediatrics / Département de pédiatrie

The ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium Montreal Children's Hospital Research Institute - McGill University Department of Pediatrics / Département de pédiatrie

Tackling childhood brain cancer at the root to improve survival and quality of life The Research Institute of the McGill University Health Centre

ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors Deutsches Krebsforschungszentrum KITZ - Hopp-Kindertumorzentrum Heidelberg

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood Deutsches Krebsforschungszentrum Klinische Kooperationseinheit Pädiatrische Onkologie

CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors Universitätsklinikum Augsburg II. Medizinische Klinik

International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour UKE - Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

HIT-REZ-REGISTRY: Multinational multicenter registry for Children, adolescent and young adult with therapy-refractory, progressive or recurrent medulloblastoma, pineoblastoma, CNS primitive neuroectodermal tumor (CNS PNET) and ependymoma Universitätsklinikum Essen Klinik für Kinderheilkunde III

Development of epigenetic classifiers for pediatric cancer (ECPC) Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu

Study of the molecular mechanisms of medulloblastoma initiation and progression Sanford Research Zhao Lab

Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis Institution: Information not provided - US

Precision medicine for pediatric low-grade gliomas Institution: Information not provided - US

Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study Institution: Information not provided - US

Regulation of medulloblastoma metastasis by emp1 Institution: Information not provided - US

Regulation of shh signaling by cellular energetics Institution: Information not provided - US

Targeting mechanisms of medulloblastoma formation Institution: Information not provided - US

Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans Institution: Information not provided - US

Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine. Institution: Information not provided - US

Targeting wee1 in myc driven medulloblasoma Institution: Information not provided - US

High-throughput Screening for SHH medulloblastoma Institution: Information not provided - US

Improving CDK 4/6 inhibition in the treatment of medulloblastoma Institution: Information not provided - US

Novel targeted therapy for childhood cancer with emphasis on Wip-1 in medulloblastoma and neuroblastoma Karolinska Institutet Department of Women's and Children's Health (KBH)

INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma Karolinska Institutet Department of microbiology, tumor and cell biology (MTC)

Adjuvant multimodal metabolic therapy of neuroblastoma Universitätsklinikum der Paracelsus Medizinischen Privatuniversität Universitätsklinik für Kinder- und Jugendheilkunde

Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study Allgemeines Krankenhaus der Stadt Wien Universitätsklinik für klinische Pharmakologie

LIQUIDHOPE: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas - AT St. Anna Kinderkrebsforschung Children's Cancer Research Institute

PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - AT St. Anna Kinderkrebsforschung Children's Cancer Research Institute

A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta - AT St. Anna Kinderkrebsforschung Children's Cancer Research Institute

Elimination of Hypoxia Inducible Factor 2 (HIF-2) in neuroblastoma tumor stem cells to stop its metastasis Seoul National University Hospital Molecular Diagnostics Laboratory

Lessons learned from the embryo to help understand neuroblastoma formation University of Helsinki Department of Biochemistry and Developmental Biology

Metastatic program of neuroblastoma: elucidating the molecular dialogues of tumor cells with the embryonic microenvironment Institut NeuroMyoGène NEURO-DÉVELOPPEMENT, CANCER ET SIGNALISATION

PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - FR Institution: Information not provided - FR

Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families Universitätsmedizin Mannheim Kinderchirurgische Klinik

Molecular basis for tumor suppression and spontanous regression in neuroblastoma Universitätsklinikum Köln Pädiatrische Onkologie und Hämatologie

NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

New nanotools for the treatment of metastatic neuroblastoma Vall d'Hebron Institut de Recerca VHIR Vall d'Hebron Institut de Recerca

Neuroblastoma: mechanotherapeutic strategies based on 3D model and patient derived tumor with vitronectin rich microenvironment INCLIVA - Sede central Fundación Investigación Clínico de Valencia - Instituto de Investigación Sanitaria

Mechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases ISCIII - Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Enfermedades Raras

Drug repurposing screening for rare and neglected diseases National Center for Advancing Translational Sciences (NCATS-NIH) Therapeutic Development Branch

Targeting olig2 co-regulators for malignant glioma therapy Institution: Information not provided - US

Deconstruct tumor microenvironment in medulloblastoma Institution: Information not provided - US

Focal sustained release chemotherapy-loaded biomaterials at tumor sites Institution: Information not provided - US

Targeting bet-bromodomains in neuroblastoma Institution: Information not provided - US

Deciphering the functional role of ALK and TWIST1 in neuroblastoma development and progression CHUV Institut universitaire de Pathologie

RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence - AT Institution: Information not provided - AT

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma - AT Institution: Information not provided - AT

Decoding cellular senescence in glioblastoma (GlioAge) Allgemeines Krankenhaus der Stadt Wien Abteilung für Neuropathologie und Neurochemie

New therapeutic treatments for malignant glioma Itä-Suomen yliopisto A.I.Virtanen -Instituutti

GliMR2.0: Glioma MR Imaging 2.0 - AT
Institution: Information not provided - AT

GliomaSignals: Metabolic control of tumour growth and epileptogenesis: the case of gliomas
European Commission

DG Research - Directorate General for Research

GliomaSignals: Metabolic control of tumour growth and epileptogenesis: the case of gliomas
Inserm-ANRS

Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)

Functional role of genes and pathways in histone H3 mutated gliomas
Institut für Neuropathologie der Medizinischen Fakultät Münster

Institut für Neuropathologie

GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients
Universitätsmedizin Mainz

Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Beaumont Hospital

Medical Oncology Service

Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Cancer Trials Ireland

Potential predictive biomarkers of anti-RTKs therapy response in gliomas: An in vitro and in vivo Study.
Universidade do Minho

Grupo de Neurociências

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa

Unidade de Investigação e Desenvolvimento

Novel strategies to target treatment resistance in gliomas, focusing on tumor micro-environment and its regulators
Instituto de Investigación Hospital 12 de Octubre

Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre

Molecular and Cellular Mechanisms of Choroid Plexus Tumor
Sanford Research

Zhao Lab

Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
Institution: Information not provided - US

Targeting Prostaglandin Receptor EP2 for Glioma and Associated Epilepsy
Institution: Information not provided - US

CeNo2 - Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem - SE
Karolinska Universitetssjukhuset

Karolinska University Hospital

Molecular mechanisms of the origine of glioma development
Uppsala Universitet

Department of immunology, Genetics and Pathology, IGP

Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
Universitätsspital Inselspital

Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

To reveal and target molecular interactions causative for pro-invasive signaling in malignant brain tumors
Universitäts-Kinderspital Zürich

Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

Rational Small Molecule Inhibition of Dissemination (RaSMID) for pediatric brain tumors
Universitäts-Kinderspital Zürich

Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien

Universitätsklinik für Kinder- und Jugendheilkunde

PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH

ITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien

Institut für Krebsforschung

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT
St. Anna Kinderkrebsforschung

Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel

Universitair Ziekenhuis Brussel (UZ Brussel)

Glioma2015: Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients and Setting up a Large-scale, Prospective Database for Glioma Patients Treated in UZ Leuven
UZ Leuven - Campus Gasthuisberg

Dienst Neurochirurgie

Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Identification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University

Department of Pediatrics / Département de pédiatrie

Role of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University

Department of Pediatrics / Département de pédiatrie

The ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University

Department of Pediatrics / Département de pédiatrie

Tackling childhood brain cancer at the root to improve survival and quality of life
The Research Institute of the McGill University Health Centre

ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum

KITZ - Hopp-Kindertumorzentrum Heidelberg

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum

Klinische Kooperationseinheit Pädiatrische Onkologie

CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors
Universitätsklinikum Augsburg

II. Medizinische Klinik

International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour
UKE - Universitätsklinikum Hamburg-Eppendorf

Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

HIT-REZ-REGISTRY: Multinational multicenter registry for Children, adolescent and young adult with therapy-refractory, progressive or recurrent medulloblastoma, pineoblastoma, CNS primitive neuroectodermal tumor (CNS PNET) and ependymoma
Universitätsklinikum Essen

Klinik für Kinderheilkunde III

Development of epigenetic classifiers for pediatric cancer (ECPC)
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu

Study of the molecular mechanisms of medulloblastoma initiation and progression
Sanford Research

Zhao Lab

Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis
Institution: Information not provided - US

Precision medicine for pediatric low-grade gliomas
Institution: Information not provided - US

Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US

Regulation of medulloblastoma metastasis by emp1
Institution: Information not provided - US

Regulation of shh signaling by cellular energetics
Institution: Information not provided - US

Targeting mechanisms of medulloblastoma formation
Institution: Information not provided - US

Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US

Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US

Targeting wee1 in myc driven medulloblasoma
Institution: Information not provided - US

High-throughput Screening for SHH medulloblastoma
Institution: Information not provided - US

Improving CDK 4/6 inhibition in the treatment of medulloblastoma
Institution: Information not provided - US

Novel targeted therapy for childhood cancer with emphasis on Wip-1 in medulloblastoma and neuroblastoma
Karolinska Institutet

Department of Women's and Children's Health (KBH)

INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma
Karolinska Institutet

Department of microbiology, tumor and cell biology (MTC)

Adjuvant multimodal metabolic therapy of neuroblastoma
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität

Universitätsklinik für Kinder- und Jugendheilkunde

Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien

Universitätsklinik für klinische Pharmakologie

LIQUIDHOPE: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas - AT
St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - AT
St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta - AT
St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

Elimination of Hypoxia Inducible Factor 2 (HIF-2) in neuroblastoma tumor stem cells to stop its metastasis
Seoul National University Hospital

Molecular Diagnostics Laboratory

Lessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki

Department of Biochemistry and Developmental Biology

Metastatic program of neuroblastoma: elucidating the molecular dialogues of tumor cells with the embryonic microenvironment
Institut NeuroMyoGène

NEURO-DÉVELOPPEMENT, CANCER ET SIGNALISATION

PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - FR
Institution: Information not provided - FR

Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
Universitätsmedizin Mannheim

Kinderchirurgische Klinik

Molecular basis for tumor suppression and spontanous regression in neuroblastoma
Universitätsklinikum Köln

Pädiatrische Onkologie und Hämatologie

NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig

Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

New nanotools for the treatment of metastatic neuroblastoma
Vall d'Hebron Institut de Recerca VHIR

Vall d'Hebron Institut de Recerca

Neuroblastoma: mechanotherapeutic strategies based on 3D model and patient derived tumor with vitronectin rich microenvironment
INCLIVA - Sede central

Fundación Investigación Clínico de Valencia - Instituto de Investigación Sanitaria

Mechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases
ISCIII - Instituto de Salud Carlos III

Centro de Investigación Biomédica en Red de Enfermedades Raras

Drug repurposing screening for rare and neglected diseases
National Center for Advancing Translational Sciences (NCATS-NIH)

Therapeutic Development Branch

Targeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

Deconstruct tumor microenvironment in medulloblastoma
Institution: Information not provided - US

Focal sustained release chemotherapy-loaded biomaterials at tumor sites
Institution: Information not provided - US

Targeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US

Deciphering the functional role of ALK and TWIST1 in neuroblastoma development and progression
CHUV

Institut universitaire de Pathologie

RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence - AT
Institution: Information not provided - AT

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma - AT
Institution: Information not provided - AT

Decoding cellular senescence in glioblastoma (GlioAge)
Allgemeines Krankenhaus der Stadt Wien

Abteilung für Neuropathologie und Neurochemie

New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto

A.I.Virtanen -Instituutti

LAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland

Faculty of Health Sciences

Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
LBP - Laboratory of Bioimaging and Pathologies

Tumoral signaling and therapeutic targets

Vessel co-option and radioresistance in glioblastoma
CLCC Institut Curie

Institut Curie

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy

Pharmaxon